Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:actinomycin_D
|
| gptkbp:appointed_by |
injection
|
| gptkbp:approves |
gptkb:1964
gptkb:FDA |
| gptkbp:contraindication |
pregnancy
breastfeeding active infections severe liver disease |
| gptkbp:dosage_form |
gptkb:software_framework
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cosmegen
|
| gptkbp:indication |
gptkb:healthcare_organization
gptkb:gestational_trophoblastic_neoplasia gptkb:Wilms'_tumor |
| gptkbp:ingredients |
dactinomycin
C62 H86 N12 O16 |
| gptkbp:interacts_with |
live vaccines
other chemotherapy drugs |
| gptkbp:is_used_for |
treatment of cancer
|
| gptkbp:manager |
intravenous
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:packaging |
vial
|
| gptkbp:side_effect |
nausea
vomiting hair loss low blood cell counts |
| gptkbp:storage |
room temperature
|
| gptkbp:weight |
1155.4 g/mol
|